Identifying Strategies for Improving Pre-exposure Prophylaxis Adherence: Perspectives from a Sample of Highly Adherent Young Men Who have Sex with Men.
Assets
HIV
MSM
Positive deviance
PrEP
Resilience
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
accepted:
01
07
2022
pubmed:
30
7
2022
medline:
11
2
2023
entrez:
29
7
2022
Statut:
ppublish
Résumé
Most research on pre-exposure prophylaxis (PrEP) adherence and persistence uses a deficit-based approach to identify negative influences on PrEP adherence; however, an alternative set of approaches (such as resilience, asset-based, and positive variation) may identify equally important positive influences on PrEP adherence. Thus, the current study presents qualitative perspectives of PrEP adherence strategies from a sample of adherent YMSM. PrEP-using YMSM living in the Chicago area from a larger cohort study were recruited into a 90-day diary study that measured sexual health behaviors including PrEP use. A subset (n = 28) were then recruited for in-depth interviews between April and September 2020 covering topics of PrEP use and adherence. Thematic analysis was used to interpret patterns within the data. The analytic sample (n = 19) consistently reported high levels of adherence. Adherence strategies were organized into three broader categories: psychological (e.g. mindfulness, pill auditing), technical/instrumental (e.g. automated reminders, pill organizers), and social strategies (e.g. checking in with friends, or getting suggestions from friends). The majority of participants described using multiple strategies and changing strategies to respond to barriers to adherence. Other themes that were related to adherence included having a daily medication history and a generally positive outlook toward the PrEP regimen. Those who had medication histories were able to draw from experience to develop strategies for PrEP adherence. Findings suggest the need for pre-emptive counseling for PrEP-initiators on the use of multiple strategies, how to prepare for PrEP adherence, to adapt to challenges, and to adopt a range of potential strategies for adherence. La mayoría de las investigaciones sobre el cumplimiento y la persistencia de la profilaxis pre-exposición (PrEP) utiliza un enfoque basado en el déficit para identificar las influencias negativas en el cumplimiento de la PrEP; sin embargo, un conjunto alternativo de enfoques (como resiliencia, basado en en las capacidades o recursos, y variación positiva) puede identificar influencias positivas igualmente importantes en la adherencia a la PrEP. Por lo tanto, el estudio actual presenta perspectivas cualitativas de las estrategias de adherencia a la PrEP de una muestra de los hombres jóvenes que tienen sexo con hombres (YMSM) adherentes. Los YMSM que usaban PrEP que vivían en la región de Chicago de un estudio de cohorte más grande fueron reclutados en un estudio diario de 90 días que midió los comportamientos de salud sexual, incluido el uso de PrEP. Luego se reclutó un subconjunto (n = 28) para entrevistas en profundidad entre abril y septiembre de 2020 que cubrieron temas de uso y adherencia a la PrEP. El análisis temático se utilizó para interpretar patrones dentro de los datos. La muestra analítica (n = 19) reportó consistentemente altos niveles de adherencia. Las estrategias de adherencia se organizaron en tres categorías más amplias: psicológicas (p. ej., atención plena, auditoría de píldoras), técnicas/instrumentales (p. ej., recordatorios automáticos, organizadores de píldoras) y estrategias sociales (p. ej., ponerse en contacto con amigos o recibir sugerencias de amigos). La mayoría de los participantes describieron el uso de múltiples estrategias y el cambio de estrategias para responder a las barreras a la adherencia. Otros temas relacionados con la adherencia incluyeron tener un historial de medicación diario y una perspectiva generalmente positiva hacia el régimen de PrEP. Aquellos que tenían antecedentes de medicación pudieron aprovechar la experiencia para desarrollar estrategias para la adherencia a la PrEP. Los hallazgos sugieren la necesidad de asesoramiento preventivo para los iniciadores de la PrEP sobre el uso de múltiples estrategias, cómo prepararse para la adherencia a la PrEP, cómo adaptarse a los desafíos y adoptar una variedad de posibles estrategias para la adherencia.
Autres résumés
Type: Publisher
(spa)
La mayoría de las investigaciones sobre el cumplimiento y la persistencia de la profilaxis pre-exposición (PrEP) utiliza un enfoque basado en el déficit para identificar las influencias negativas en el cumplimiento de la PrEP; sin embargo, un conjunto alternativo de enfoques (como resiliencia, basado en en las capacidades o recursos, y variación positiva) puede identificar influencias positivas igualmente importantes en la adherencia a la PrEP. Por lo tanto, el estudio actual presenta perspectivas cualitativas de las estrategias de adherencia a la PrEP de una muestra de los hombres jóvenes que tienen sexo con hombres (YMSM) adherentes. Los YMSM que usaban PrEP que vivían en la región de Chicago de un estudio de cohorte más grande fueron reclutados en un estudio diario de 90 días que midió los comportamientos de salud sexual, incluido el uso de PrEP. Luego se reclutó un subconjunto (n = 28) para entrevistas en profundidad entre abril y septiembre de 2020 que cubrieron temas de uso y adherencia a la PrEP. El análisis temático se utilizó para interpretar patrones dentro de los datos. La muestra analítica (n = 19) reportó consistentemente altos niveles de adherencia. Las estrategias de adherencia se organizaron en tres categorías más amplias: psicológicas (p. ej., atención plena, auditoría de píldoras), técnicas/instrumentales (p. ej., recordatorios automáticos, organizadores de píldoras) y estrategias sociales (p. ej., ponerse en contacto con amigos o recibir sugerencias de amigos). La mayoría de los participantes describieron el uso de múltiples estrategias y el cambio de estrategias para responder a las barreras a la adherencia. Otros temas relacionados con la adherencia incluyeron tener un historial de medicación diario y una perspectiva generalmente positiva hacia el régimen de PrEP. Aquellos que tenían antecedentes de medicación pudieron aprovechar la experiencia para desarrollar estrategias para la adherencia a la PrEP. Los hallazgos sugieren la necesidad de asesoramiento preventivo para los iniciadores de la PrEP sobre el uso de múltiples estrategias, cómo prepararse para la adherencia a la PrEP, cómo adaptarse a los desafíos y adoptar una variedad de posibles estrategias para la adherencia.
Identifiants
pubmed: 35906443
doi: 10.1007/s10461-022-03785-4
pii: 10.1007/s10461-022-03785-4
pmc: PMC9884315
mid: NIHMS1827657
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
506-517Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD013609
Pays : United States
Organisme : National Center on Minority Health and Health Disparities
ID : R01MD013609
Organisme : NIDA NIH HHS
ID : U01 DA036939
Pays : United States
Organisme : NIDA NIH HHS
ID : U01DA036939
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Huang X, Hou J, Song A, Liu X, Yang X, Xu J, Zhang J, Hu Q, Chen H, Chen Y, Meyers K, Wu H. Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: a systematic review and meta-analysis. Front Pharmacol. 2018;9:799.
doi: 10.3389/fphar.2018.00799
Centers for Disease Control and Prevention. HIV surveillance report, 2019; vol. 32. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Published May 2021. Accessed 28 July 2021.
Sidebottom D, Ekström AM, Strömdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV—how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):1–14.
doi: 10.1186/s12879-018-3463-4
Whitfield TH, John SA, Rendina HJ, Grov C, & Parsons JT. Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men. AIDS Behav. 2018;22(11):3566–75.
doi: 10.1007/s10461-018-2045-1
Coy KC., Hazen RJ, Kirkham HS, Delpino A, Siegler AJ. Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. J Int AIDS Soc 2019:22(2):e25252.
doi: 10.1002/jia2.25252
Morgan E, Ryan DT, Newcomb ME, Mustanski B. High rate of discontinuation may diminish PrEP coverage among young men who have sex with men. AIDS Behav. 2018;22(11):3645–8.
doi: 10.1007/s10461-018-2125-2
Maxwell S, Gafos M, Shahmanesh M. Pre-exposure prophylaxis use and medication adherence among men who have sex with men: a systematic review of the literature. J Assoc Nurses AIDS Care. 2019;30(4):e38–61.
doi: 10.1097/JNC.0000000000000105
Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214–30.
doi: 10.1001/jama.2019.2591
Hosek S, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G, Lally M, Wilson CM, the Adolescent Trials Network (ATN) for HIV/AIDS Interventions. An HIV pre-exposure prophylaxis (PrEP) demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21.
doi: 10.1097/QAI.0000000000001179
Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P. Predictors of over-reporting HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) in self-reported versus biomarker data. AIDS Behav. 2018;22(4):1174–83.
doi: 10.1007/s10461-017-1958-4
Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, McMahan V, Bushman LR, Casapía M, Montoya-Herrera O, Veloso VG, iPrEx Study Team. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.
doi: 10.1126/scitranslmed.3004006
Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S. Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics. AIDS. 2019;33(14):2189–95.
doi: 10.1097/QAD.0000000000002347
Serota DP, Rosenberg ES, Sullivan PS, Thorne AL, Rolle CPM, Del Rio C, Cutro S, Luisi N, Siegler AJ, Sanchez TH, Kelley CF. Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis. 2020;71(3):574–82.
doi: 10.1093/cid/ciz894
Coyer L, van den Elshout MA, Achterbergh RC, Matser A, van der Loeff MFS. Davidovich U, Boyd A. Understanding pre-exposure prophylaxis (PrEP) regimen use: switching and discontinuing daily and event-driven PrEP among men who have sex with men. EClinicalMedicine. 2020;29:100650.
doi: 10.1016/j.eclinm.2020.100650
Huebner DM, Mustanski B. Navigating the long road forward for maximizing PrEP impact among adolescent men who have sex with men. Arch Sex Behav. 2020;49(1):211–6.
doi: 10.1007/s10508-019-1454-1
Krause KD, Kapadia F, Ompad DC, D’Avanzo PA, Duncan DT, Halkitis PN. Early life psychosocial stressors and housing instability among young sexual minority men: the P18 cohort study. J Urban Health. 2016;93(3):511–25.
doi: 10.1007/s11524-016-0049-6
Centers for Disease Control and Prevention. Half of black gay men and a quarter of Latino gay men projected to be diagnosed within their lifetime. 2016. Available from: http://www.cdc.gov/nchhstp/newsroom/2016/croi-pressrelease-risk.html . Accessed 29 Apr 2021.
Edeza A, Karina Santamaria E, Valente PK, Gomez A, Ogunbajo A, Biello K. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies. AIDS Care. 2020;33(6):697–705.
doi: 10.1080/09540121.2020.1778628
Herrick AL, Stall R, Goldhammer H, Egan JE, Mayer KH. Resilience as a research framework and as a cornerstone of prevention research for gay and bisexual men: theory and evidence. AIDS Behav. 2014;18(1):1–9.
doi: 10.1007/s10461-012-0384-x
Fergus S, Zimmerman MA. Adolescent resilience: a framework for understanding healthy development in the face of risk. Annu. Rev. Public Health. 2005;26:399-419.
doi: 10.1146/annurev.publhealth.26.021304.144357
Chen YT, Duncan DT, Issema R, Goedel WC, Callander D, Bernard-Herman B, Hanson H, Eavou R, Schneider J, Hotton A. Social-environmental resilience, PrEP uptake, and viral suppression among young black men who have sex with men and young black transgender women: the neighborhoods and networks (N2) study in Chicago. J Urban Health. 2020;97:728–38.
doi: 10.1007/s11524-020-00425-x
Marsh DR, Schroeder DG, Dearden KA, Sternin J, Sternin M. The power of positive variation. BMJ. 2004;329(7475):1177–9.
doi: 10.1136/bmj.329.7475.1177
Ober AJ, Dangerfield DT, Shoptaw S, Ryan G, Stucky B, Friedman SR. Using a “positive variation” framework to discover adaptive risk reduction behaviors among high-risk HIV negative black men who have sex with men. AIDS Behav. 2018;22(5):1699–712.
doi: 10.1007/s10461-017-1790-x
Cassetti V, Powell K, Barnes A, Sanders T. A systematic scoping review of asset-based approaches to promote health in communities: development of a framework. Glob Health Promot. 2020;27(3):15–23.
doi: 10.1177/1757975919848925
Mayer KH, Bekker LG, Stall R, Grulich AE, Colfax G, Lama JR. Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet. 2012;380(9839):378–87.
doi: 10.1016/S0140-6736(12)60835-6
Von Hippel C. A next generation assets-based public health intervention development model: the public as innovators. Front Public Health. 2018;6:248.
doi: 10.3389/fpubh.2018.00248
Mustanski B, Morgan E, D’Aquila R, Birkett M, Janulis P, Newcomb ME. Individual and network factors associated with racial disparities in HIV among young men who have sex with men: results from the RADAR cohort study. J Acquir Immune Defic Syndr. 2019;80(1):24.
doi: 10.1097/QAI.0000000000001886
Chicago News Tribune Staff with News Services. 6 months of COVID-19: timeline of the outbreak and how politics, sports, entertainment and the economy changed. Chicago News Tribune; 2020. Available from: https://www.chicagotribune.com/coronavirus/ct-viz-coronavirus-timeline-20200507-uvrzs32nljabrpn6vkzq7m2fpq-story.html . Accessed 27 Jan 2021.
Yager J, Castillo-Mancilla J, Ibrahim ME, Brooks KM, McHugh C, Morrow M, McCallister S, Bushman LR, MaWhinney S, Kiser JJ, Anderson PL. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS study. JAIDS. 2020;84(3):323–30.
Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284.
doi: 10.1037/1040-3590.6.4.284
Salmoirago-Blotcher E, Carey MP. Can mindfulness training improve medication adherence? Integrative review of the current evidence and proposed conceptual model. Explore. 2018;14(1):59–65.
doi: 10.1016/j.explore.2017.09.010
Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964–73.
doi: 10.1007/s10461-019-02397-9
Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018;22(9):3044–56.
doi: 10.1007/s10461-018-2159-5
Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018;15(2):190–7.
doi: 10.1007/s11904-018-0385-0
Rosengren-Hovee AL, Lelutiu-Weinberger C, Woodhouse EW, Sandanapitchai P, Hightow-Weidman LB. A scoping review of HIV pre-exposure prophylaxis stigma and implications for stigma-reduction interventions for men and transwomen who have sex with men. AIDS Behav. 2021;25(7):2054–70.
doi: 10.1007/s10461-020-03135-2
Mehrotra ML, Amico KR, McMahan V, Glidden DV, Defechereux P, Guanira JV, Grant RM. The role of social relationships in PrEP uptake and use among transgender women and men who have sex with men. AIDS Behav. 2018;22(11):3673–80.
doi: 10.1007/s10461-018-2151-0
Hays RB, Rebchook GM, Kegeles SM. The Mpowerment Project: community-building with young gay and bisexual men to prevent HIV. Am J Community Psychol. 2003;31(3):301–12.
doi: 10.1023/A:1023966905973
Stein R, Shapatava E, Williams W, Griffin T, Bell K, Lyons B, Uhl G. Reduced sexual risk behaviors among young men of color who have sex with men: findings from the community-based organization behavioral outcomes of many men, many voices (CBOP-3MV) project. Prev Sci. 2015;16(8):1147–58.
doi: 10.1007/s11121-015-0565-8
Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50.
doi: 10.1007/s10461-015-1164-1
Dehlin JM, Stillwagon R, Pickett J, Keene L, Schneider JA. # PrEP4Love: an evaluation of a sex-positive HIV prevention campaign. JMIR Public Health Surveill. 2019;5(2): e12822.
doi: 10.2196/12822